Current HIV Research
Title: Editorial [Nef: A Notorious Enigmatic Factor in HIV Biology (Guest Editor: Bruno Verhasselt)]
Volume: 9 Issue: 7
Author(s): Bruno Verhasselt
Affiliation:
Export Options
About this article
Cite this article as:
Verhasselt Bruno, Editorial [Nef: A Notorious Enigmatic Factor in HIV Biology (Guest Editor: Bruno Verhasselt)], Current HIV Research 2011; 9(7) . https://dx.doi.org/10.2174/157016211798842071
DOI https://dx.doi.org/10.2174/157016211798842071 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Article Metrics

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Identification of <i>In Vivo</i> Metabolites of a Potential Anti-tumor Drug Candidate AMAC, in Rat Plasma, Urine and Feces Samples Using UHPLC/QTOF /MS/MS
Current Pharmaceutical Analysis Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)]
Current Cancer Drug Targets Pharmacological Modulation of p53 Function in Cancer Therapy
Current Signal Transduction Therapy Design, Synthesis and Evaluation of 5-pyridin-4-yl-2-thioxo-[1,3,4]oxadiazol-3-yl Derivatives as Anti-angiogenic Agents Targeting VEGFR-2
Anti-Cancer Agents in Medicinal Chemistry ENaC Modulators and Renal Disease
Current Molecular Pharmacology Perspective of MiRNAs in Clinical Glioblastoma Research
Current Signal Transduction Therapy Development of Drug Targeting and Delivery in Cervical Cancer
Current Cancer Drug Targets Thymidine Phosphorylase (Platelet-Derived Endothelial Cell Growth Factor) as a Target for Capecitabine: From Biology to the Bedside
Recent Patents on Anti-Cancer Drug Discovery Tuftsin – Properties and Analogs
Current Medicinal Chemistry Taming Oncogenic Signaling at Protein Interfaces: Challenges and Opportunities
Current Topics in Medicinal Chemistry Potential Natural Dual Agonist PPARα/γ-induced Antidiabetic and Antidyslipidemic Properties of Safrole-Free Nutmeg Seed (Myristica fragrans Houtt) Extract
The Natural Products Journal Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents
Recent Patents on Drug Delivery & Formulation Flavonoid Antioxidants
Current Medicinal Chemistry Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer
Current Cancer Drug Targets Solution NMR Study of the Transmembrane Domain of Single-Span Membrane Proteins: Opportunities and Strategies
Current Protein & Peptide Science Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy
Mini-Reviews in Medicinal Chemistry Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy Microsomal Prostaglandin E2 Synthase-1 as a New Macromolecular Drug Target in the Prevention of Inflammation and Cancer
Anti-Cancer Agents in Medicinal Chemistry Models of Antigen Receptor Activation in the Design of Vaccines
Current Pharmaceutical Design